SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

TriSalus Life Sciences, Inc.
Date: June 6, 2025 · CIK: 0001826667 · Accession: 0001104659-25-057451

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287696

Date
June 6, 2025
Author
Mary Szela
Form
CORRESP
Company
TriSalus Life Sciences, Inc.

Letter

TriSalus Life Sciences, Inc.

6272 W. 91 st Ave.

Westminster, Colorado 80031

June 6, 2025

Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F. Street N.E.

Washington, D.C. 20549-3010

Attention: Nicholas O'Leary

Re: TriSalus Life Sciences, Inc.

Registration Statement on Form S-3

May 30, 2025

File No. 333-287696

Ladies and Gentlemen:

TriSalus Life Sciences, Inc. (the " Registrant ") hereby requests that the U.S. Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on Wednesday, June 11, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Dylan Kornbluth of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Dylan Kornbluth of Cooley LLP, counsel to the Registrant, at (858) 550-6173.

[ Signature Page Follows ]

Very truly yours,
TRISALUS LIFE SCIENCES, INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 TriSalus
Life Sciences, Inc.

 6272 W. 91 st Ave.

 Westminster, Colorado 80031

 June 6, 2025

 Securities and Exchange Commission

 Division of Corporation Finance

 Office of Industrial Applications
and Services

 100 F. Street N.E.

 Washington, D.C. 20549-3010

 Attention: Nicholas O'Leary

 Re:
 TriSalus Life Sciences, Inc.

 Registration Statement on Form S-3

 May 30, 2025

 File No. 333-287696

 Ladies and Gentlemen:

 TriSalus Life Sciences, Inc. (the " Registrant ")
hereby requests that the U.S. Securities and Exchange Commission (the " Commission ") take appropriate action to cause
the above-referenced Registration Statement on Form S-3 to become effective on Wednesday, June 11, 2025, at 4:00 p.m., Eastern Time, or
as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the
Commission. The Registrant hereby authorizes Dylan Kornbluth of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

 Once the Registration Statement has
been declared effective, please orally confirm that event with Dylan Kornbluth of Cooley LLP, counsel to the Registrant, at (858) 550-6173.

 [ Signature Page Follows ]

 Very truly yours,

 TRISALUS LIFE SCIENCES, INC.

 By:
 /s/ Mary Szela

 Name:
 Mary Szela

 Title:
 Chief Executive Officer

 cc:
 Carlos Ramirez, Cooley LLP

 Matthew T. Browne, Cooley LLP

 Dylan Kornbluth, Cooley LLP

 [Company
Signature Page to Acceleration Request]